VCYT
VERACYTE, INC.
$47.33
-0.19%
$3.8B
No data for this timeframe.
Vol
Market Cap$3.8B
Cap SizeMid Cap
Analyst ConsensusStrong Buy (83%)
Inst. Holders50 funds
Inst. Value$2.2B
Inst. Activity23 buys / 9 sells
Insider Activity0B / 11S
Insider Net $-$10.7M
SEC Reports9
Recent Activity
Jun 11, 2026
SEC
A significant institutional cluster in VCYT shows 15 buyers accumulating $175.7M net versus 13 sellers reducing by $12.4
INST-CLUSTER — Impact 6/10
Jun 5, 2026
SEC
Insider selling cluster at Veracyte: CEO Marc Stapley sold 138,051 shares for $6.9M and Global Chief Commercial Officer
CLUSTER — Impact 4/10
Jun 4, 2026
Insider
Stapley Marc acquired via exercise 138,051 shares
Chief Executive Officer @ $36.60 ($5.1M)
Jun 4, 2026
Insider
Stapley Marc sold 138,051 shares
Chief Executive Officer @ $50.12 ($6.9M)
Jun 4, 2026
Insider
Leite John sold 13,975 shares
Global Chief Commercial Off @ $50.07 ($699.7K)
May 27, 2026
SEC
Two insiders at Veracyte sold a total of $1.53M in open-market sales over a 7-day window. The VP and Chief Accounting Of
CLUSTER — Impact 3/10
Inst.
FMR LLC — ADD
7,763,849 shares ($250.1M)
Inst.
WELLINGTON MANAGEMENT GROUP LLP — ADD
2,558,285 shares ($82.4M)
Price Targets
$49.10
+3.7% upside
Hold
Current $47.33
Low $37.00
Median $50.50
High $57.00
10 analysts
$37.00
$57.00
Analyst Ratings
8Strong Buy
7Buy
2Hold
1Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jun 1, 2026 | Needham | MAINTAIN | Buy → Buy |
| May 28, 2026 | Needham | REITERATE | Buy → Buy |
| May 6, 2026 | Canaccord Genuity | MAINTAIN | Hold → Hold |
| May 6, 2026 | UBS | MAINTAIN | Buy → Buy |
| Apr 20, 2026 | Canaccord Genuity | MAINTAIN | Hold → Hold |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $0.43 ▲ +3.3% | $0.40 — $0.47 | -2% YoY | 10 |
| Next Q | $0.43 ▼ -0.6% | $0.38 — $0.47 | -15% YoY | 10 |
| Current FY | $1.82 ▲ +10.5% | $1.71 — $1.95 | 2% YoY | 10 |
| Next FY | $1.90 ▲ +7.7% | $1.74 — $2.10 | 4% YoY | 10 |
Latest Reports
BULLISH
INST-CLUSTER
6/10
A significant institutional cluster in VCYT shows 15 buyers accumulating $175.7M net versus 13 sellers reducing by $12.4
Jun 11, 2026
NEUTRAL
CLUSTER
4/10
Insider selling cluster at Veracyte: CEO Marc Stapley sold 138,051 shares for $6.9M and Global Chief Commercial Officer
Jun 5, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| BlackRock, Inc. | $424.3M | — |
| FMR LLC | $250.1M | ADD |
| Artisan Partners Limited Partnership | $177.0M | — |
| STATE STREET CORP | $162.5M | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $143.2M | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 4, 2026 | Stapley Marc | M | $5.1M |
| Jun 4, 2026 | Stapley Marc | SELL | $6.9M |
| Jun 4, 2026 | Leite John | SELL | $699.7K |
| Jun 4, 2026 | Chambers Rebecca | SELL | $78.9K |
| Jun 4, 2026 | McGuire Annie | SELL | $69.0K |
50 institutional holders with $2.2B total value (67,877,919 shares) as of 2026-Q1. Top holders: BlackRock,, FMR, Artisan. Net buying activity: 23 institutions added/increased vs 9 reduced.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 13,172,618 | $424.3M | 19.4% | — |
| 2 | FMR LLC | 7,763,849 | $250.1M | 11.4% | ADD +35.3% |
| 3 | Artisan Partners Limited Partnership | 5,496,370 | $177.0M | 8.1% | — |
| 4 | STATE STREET CORP | 5,043,590 | $162.5M | 7.4% | — |
| 5 | VANGUARD PORTFOLIO MANAGEMENT LLC | 4,444,730 | $143.2M | 6.5% | — |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 3,532,232 | $113.8M | 5.2% | — |
| 7 | ARK Investment Management LLC | 3,053,818 | $98.4M | 4.5% | — |
| 8 | DIMENSIONAL FUND ADVISORS LP | 2,881,090 | $92.8M | 4.2% | — |
| 9 | WELLINGTON MANAGEMENT GROUP LLP | 2,558,285 | $82.4M | 3.8% | ADD +25.6% |
| 10 | FIRST TRUST ADVISORS LP | 2,117,046 | $68.2M | 3.1% | ADD +64.9% |
| 11 | BANK OF AMERICA CORP /DE/ | 1,448,897 | $46.7M | 2.1% | — |
| 12 | FULLER & THALER ASSET MANAGEMENT, INC. | 1,414,362 | $45.6M | 2.1% | NEW |
| 13 | GOLDMAN SACHS GROUP INC | 1,276,260 | $41.1M | 1.9% | — |
| 14 | Sumitomo Mitsui Trust Group, Inc. | 1,055,656 | $34.0M | 1.6% | — |
| 15 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 989,687 | $31.9M | 1.5% | ADD +25.2% |
| 16 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 923,573 | $29.7M | 1.4% | — |
| 17 | Legal & General Group Plc | 897,171 | $28.9M | 1.3% | ADD +29.9% |
| 18 | Alyeska Investment Group, L.P. | 808,570 | $26.0M | 1.2% | ADD +34.4% |
| 19 | MORGAN STANLEY | 797,802 | $25.7M | 1.2% | TRIM -32.6% |
| 20 | BAMCO INC /NY/ | 655,522 | $21.1M | 1.0% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| FMR LLC | ADD | 5,738,209 | 7,763,849 | +35.3% | $250.1M | 2026-Q1 |
| WELLINGTON MANAGEMENT GROUP LLP | ADD | 2,036,386 | 2,558,285 | +25.6% | $82.4M | 2026-Q1 |
| FIRST TRUST ADVISORS LP | ADD | 1,283,503 | 2,117,046 | +64.9% | $68.2M | 2026-Q1 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | ADD | 790,425 | 989,687 | +25.2% | $31.9M | 2026-Q1 |
| Legal & General Group Plc | ADD | 690,757 | 897,171 | +29.9% | $28.9M | 2026-Q1 |
| Alyeska Investment Group, L.P. | ADD | 601,556 | 808,570 | +34.4% | $26.0M | 2026-Q1 |
| MORGAN STANLEY | TRIM | 1,183,069 | 797,802 | -32.6% | $25.7M | 2026-Q1 |
| Nuveen, LLC | TRIM | 582,274 | 238,439 | -59.1% | $7.7M | 2026-Q1 |
| PRUDENTIAL FINANCIAL INC | ADD | 148,905 | 190,910 | +28.2% | $6.1M | 2026-Q1 |
| JANUS HENDERSON GROUP PLC | TRIM | 271,623 | 187,368 | -31.0% | $6.0M | 2026-Q1 |
| Neuberger Berman Group LLC | DOUBLED | 5,068 | 150,805 | +2875.6% | $4.9M | 2026-Q1 |
| EXCHANGE TRADED CONCEPTS, LLC | ADD | 110,944 | 145,925 | +31.5% | $4.7M | 2026-Q1 |
| Trexquant Investment LP | DOUBLED | 7,859 | 130,159 | +1556.2% | $4.2M | 2026-Q1 |
| PANAGORA ASSET MANAGEMENT INC | TRIM | 131,706 | 93,941 | -28.7% | $3.0M | 2026-Q1 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | ADD | 55,044 | 91,401 | +66.1% | $2.9M | 2026-Q1 |
| ENVESTNET ASSET MANAGEMENT INC | ADD | 62,449 | 86,098 | +37.9% | $2.8M | 2026-Q1 |
| Universal- Beteiligungs- und Servicegesellschaft mbH | TRIM | 138,087 | 64,682 | -53.2% | $2.1M | 2026-Q1 |
| FIFTH THIRD BANCORP | DOUBLED | 506 | 52,549 | +10285.2% | $1.7M | 2026-Q1 |
| VOYA INVESTMENT MANAGEMENT LLC | ADD | 35,807 | 48,968 | +36.8% | $1.6M | 2026-Q1 |
| Connor, Clark & Lunn Investment Management Ltd. | ADD | 35,701 | 47,707 | +33.6% | $1.5M | 2026-Q1 |
| Cerity Partners LLC | DOUBLED | 9,077 | 38,183 | +320.7% | $1.2M | 2026-Q1 |
| STIFEL FINANCIAL CORP | TRIM | 48,326 | 30,037 | -37.8% | $967.5K | 2026-Q1 |
| CANADA PENSION PLAN INVESTMENT BOARD | ADD | 15,500 | 19,800 | +27.7% | $637.8K | 2026-Q1 |
| Amundi | NEAR_EXIT | 128,712 | 12,124 | -90.6% | $390.5K | 2026-Q1 |
| QRG CAPITAL MANAGEMENT, INC. | TRIM | 39,270 | 10,975 | -72.1% | $353.5K | 2026-Q1 |
8 unique insiders with 37 transactions. Net insider value: -$10.7M ($0.00 bought, $10.7M sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 4, 2026 | Stapley Marc | Chief Executive Officer | EXERCISE | 138,051 | $36.60 | $5.1M |
| Jun 4, 2026 | Stapley Marc | Chief Executive Officer | SELL | 138,051 | $50.12 | $6.9M |
| Jun 4, 2026 | Leite John | Global Chief Commercial Off | SELL | 13,975 | $50.07 | $699.7K |
| Jun 4, 2026 | Chambers Rebecca | Chief Financial Officer | SELL | 1,600 | $49.28 | $78.9K |
| Jun 4, 2026 | McGuire Annie | EVP, General Counsel | SELL | 1,400 | $49.31 | $69.0K |
| Jun 2, 2026 | Febbo Phillip G. | Chief Scientific & Med Officer | TAX W/H | 3,730 | $47.80 | $178.3K |
| Jun 2, 2026 | Stapley Marc | Chief Executive Officer | TAX W/H | 9,012 | $47.80 | $430.8K |
| Jun 2, 2026 | Chambers Rebecca | Chief Financial Officer | TAX W/H | 3,693 | $47.80 | $176.5K |
| Jun 2, 2026 | Leite John | Global Chief Commercial Off | TAX W/H | 4,059 | $47.80 | $194.0K |
| Jun 2, 2026 | Wygant Jonathan | VP, Chief Accounting Officer | TAX W/H | 1,361 | $47.80 | $65.1K |
| Jun 2, 2026 | McGuire Annie | EVP, General Counsel | TAX W/H | 3,292 | $47.80 | $157.4K |
| May 22, 2026 | Wygant Jonathan | VP, Chief Accounting Officer | EXERCISE | 24,000 | $24.80 | $595.2K |
| May 22, 2026 | Wygant Jonathan | VP, Chief Accounting Officer | SELL | 24,000 | $45.40 | $1.1M |
| May 20, 2026 | EPSTEIN ROBERT S | Director | SELL | 10,000 | $44.01 | $440.1K |
| May 6, 2026 | McGuire Annie | SVP, General Counsel | SELL | 5,102 | $38.05 | $194.1K |
| Apr 10, 2026 | Haas Kevin Richard | Chief Dev and Tech Officer | AWARD | 44,221 | — | — |
| Mar 6, 2026 | McGuire Annie | SVP, General Counsel | AWARD | 32,892 | — | — |
| Mar 6, 2026 | Stapley Marc | Chief Executive Officer | AWARD | 92,099 | — | — |
| Mar 6, 2026 | Wygant Jonathan | VP, Chief Accounting Officer | AWARD | 10,525 | — | — |
| Mar 6, 2026 | Febbo Phillip G. | Chief Scientific & Med Officer | AWARD | 29,603 | — | — |
| Mar 6, 2026 | Chambers Rebecca | Chief Financial Officer | AWARD | 36,181 | — | — |
| Mar 6, 2026 | Leite John | Chief Commercial Officer-CLIA | AWARD | 36,181 | — | — |
| Mar 4, 2026 | Leite John | Chief Commercial Officer-CLIA | SELL | 5,260 | $35.19 | $185.1K |
| Mar 4, 2026 | McGuire Annie | SVP, General Counsel | SELL | 4,994 | $35.29 | $176.3K |
| Mar 4, 2026 | Chambers Rebecca | Chief Financial Officer | SELL | 4,400 | $35.55 | $156.4K |
| Mar 4, 2026 | Stapley Marc | Chief Executive Officer | SELL | 19,244 | $35.56 | $684.2K |
| Mar 2, 2026 | Wygant Jonathan | VP, Chief Accounting Officer | TAX W/H | 3,006 | $36.01 | $108.2K |
| Mar 2, 2026 | Chambers Rebecca | Chief Financial Officer | TAX W/H | 7,234 | $36.01 | $260.5K |
| Mar 2, 2026 | Stapley Marc | Chief Executive Officer | TAX W/H | 19,455 | $36.01 | $700.6K |
| Mar 2, 2026 | McGuire Annie | SVP, General Counsel | TAX W/H | 6,902 | $36.01 | $248.5K |
| Mar 2, 2026 | Febbo Phillip G. | Chief Scientific & Med Officer | TAX W/H | 6,035 | $36.01 | $217.3K |
| Mar 2, 2026 | Leite John | Chief Commercial Officer-CLIA | TAX W/H | 7,517 | $36.01 | $270.7K |
| Feb 26, 2026 | McGuire Annie | SVP, General Counsel | AWARD | 50,999 | — | — |
| Feb 26, 2026 | Febbo Phillip G. | Chief Scientific & Med Officer | AWARD | 71,806 | — | — |
| Feb 26, 2026 | Stapley Marc | Chief Executive Officer | AWARD | 139,074 | — | — |
| Feb 26, 2026 | Leite John | Chief Commercial Officer-CLIA | AWARD | 47,149 | — | — |
| Feb 26, 2026 | Chambers Rebecca | Chief Financial Officer | AWARD | 59,324 | — | — |
9 SEC filing reports analyzed. Sentiment: 3 bullish, 1 bearish, 0 mixed, 5 neutral. Avg impact: 4.9/10.
BULLISH
INST-CLUSTER
6/10
A significant institutional cluster in VCYT shows 15 buyers accumulating $175.7M net versus 13 selle
Jun 11, 2026
NEUTRAL
CLUSTER
4/10
Insider selling cluster at Veracyte: CEO Marc Stapley sold 138,051 shares for $6.9M and Global Chief
Jun 5, 2026
NEUTRAL
CLUSTER
3/10
Two insiders at Veracyte sold a total of $1.53M in open-market sales over a 7-day window. The VP and
May 27, 2026
NEUTRAL
144
2/10
Director Robert Epstein filed a Form 144 on May 20, 2026, indicating intent to sell 10,000 common sh
May 20, 2026
BULLISH
8-K
8/10
Veracyte reported Q1 2026 earnings with total revenue of $139.1M (+21% YoY) and GAAP diluted EPS of
May 5, 2026
NEUTRAL
DEFA14A
3/10
Verae Technologies, Inc. (VCYT) filed a definitive additional proxy materials (DEFA14A) notice ahead
Apr 22, 2026
BEARISH
CLUSTER
6/10
Multiple C-suite executives at Veracyte sold shares in a coordinated open-market transaction cluster
Mar 10, 2026
NEUTRAL
CLUSTER
4/10
Multiple executives at Veracyte sold shares in a concentrated 7-day window, including $1.2M in open-
Mar 6, 2026
BULLISH
8-K
8/10
Veracyte reported strong fourth quarter and full year 2025 financial results, with Q4 total revenue
Feb 25, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Buy (83% buy). Based on 18 analysts: 8 strong buy, 7 buy, 2 hold, 1 sell, 0 strong sell.
Analyst Price Targets
$49.10 mean target
+3.7% upside
Hold (1.64)
$37.00 Low
$57.00 High
| Metric | Value |
|---|---|
| Current Price | $47.33 |
| Target Low | $37.00 |
| Target Mean | $49.10 |
| Target Median | $50.50 |
| Target High | $57.00 |
| # Analysts | 10 |
| Recommendation | Hold (1.64) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.43 | $0.40 | $0.47 | -1.6% | +3.3% | 6↑ 2↓ | $0.1B | 11.0% | 10 |
| Next Q 2026-09-30 |
$0.43 | $0.38 | $0.47 | -15.1% | -0.6% | 3↑ 3↓ | $0.1B | 12.7% | 10 |
| Current FY 2026-12-31 |
$1.82 | $1.71 | $1.95 | 2.3% | +10.5% | 6↑ 0↓ | $0.6B | 13.3% | 10 |
| Next FY 2027-12-31 |
$1.90 | $1.74 | $2.10 | 4.4% | +7.7% | 6↑ 0↓ | $0.7B | 11.6% | 10 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $0.433 | |
| 7d ago | $0.435 | -0.002 |
| 30d ago | $0.419 | +0.014 |
| 60d ago | $0.417 | +0.016 |
| 90d ago | $0.412 | +0.021 |
6 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 1 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Jun 1, 2026 | Needham | MAINTAIN | Buy | Buy |
| May 28, 2026 | Needham | REITERATE | Buy | Buy |
| May 6, 2026 | Canaccord Genuity | MAINTAIN | Hold | Hold |
| May 6, 2026 | UBS | MAINTAIN | Buy | Buy |
| Apr 20, 2026 | Canaccord Genuity | MAINTAIN | Hold | Hold |
| Apr 13, 2026 | Jefferies | INITIATE | — | Buy |
| Apr 1, 2026 | Needham | MAINTAIN | Buy | Buy |
| Mar 30, 2026 | Guggenheim | MAINTAIN | Buy | Buy |
| Mar 6, 2026 | Morgan Stanley | MAINTAIN | Underweight | Underweight |
| Feb 26, 2026 | Needham | MAINTAIN | Buy | Buy |
| Jan 5, 2026 | Guggenheim | MAINTAIN | Buy | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 8 | 7 | 2 | 1 | 0 | 83% | |
| May 1, 2026 | 8 | 8 | 2 | 1 | 0 | 84% | |
| Apr 1, 2026 | 7 | 8 | 3 | 1 | 0 | 79% | |
| Mar 1, 2026 | 7 | 8 | 3 | 1 | 0 | 79% | |
| Feb 1, 2026 | 7 | 8 | 3 | 1 | 0 | 79% | |
| Jan 1, 2026 | 7 | 8 | 3 | 1 | 0 | 79% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 18, 2026
short_volume
Short Volume: VCYT — 64.2% short (0.4M / 0.6M)
Short: 375,762 | Exempt: 111 | TRF Vol: 585,040 | Short Ratio: 64.2% | Off-exchange volume (dark pool + OTC)
May 8, 2026
short_interest
FTD: VCYT — 116,620 shares ($4.8M) failed to deliver
Settlement: 20260508, Price: $40.76, FTD Value: $4,753,431.2, VERACYTE INC COM
May 7, 2026
short_volume
Short Volume: VCYT — 79.7% short (0.5M / 0.7M)
Short: 529,938 | Exempt: 97,565 | TRF Vol: 665,273 | Short Ratio: 79.7% | Off-exchange volume (dark pool + OTC)
May 5, 2026
short_volume
Short Volume: VCYT — 73.0% short (0.4M / 0.5M)
Short: 378,928 | Exempt: 0 | TRF Vol: 519,247 | Short Ratio: 73.0% | Off-exchange volume (dark pool + OTC)
May 5, 2026
earnings_calendar
VCYT Q1 2026 Earnings After Market Close — 2026-05-05
Feb 25, 2026
earnings_calendar
VCYT Q4 2025 Earnings After Market Close — 2026-02-25